WallStreetZenWallStreetZen

NASDAQ: PBM
Psyence Biomedical Ltd Stock

$0.54+0.00 (+0%)
Updated Feb 23, 2024
PBM Price
$0.54
Fair Value Price
N/A
Market Cap
$7.28M
52 Week Low
$0.51
52 Week High
$14.55
P/E
-54.4x
P/B
-0.45x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
$1.52M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
-1.79
Operating Cash Flow
-$1M
Beta
-0.14
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

PBM Overview

Newcourt Acquisition Corp. is a "blank check" company formed to effect mergers, stock purchases, or similar combinations with one or more businesses. It targets digital financial services and fintech companies with exposure to emerging markets. Newcourt Acquisition founded in 2021 and is headquartered in Oakland, CA.

Zen Score

Industry Average (22)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how PBM scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

PBM is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
PBM is unprofitable, so we are unable to assess its PEG ratio
PEG Value Valuation
PBM's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
There are 30 more PBM due diligence checks available for Premium users.

Be the first to know about important PBM news, forecast changes, insider trades & much more!

PBM News

Valuation

PBM fair value

Fair Value of PBM stock based on Discounted Cash Flow (DCF)
Price
$0.54
Fair Value
$6.17
Undervalued by
91.25%
PBM is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

PBM price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-54.4x
Industry
16.16x
Market
33.56x

PBM price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
-0.45x
Industry
6.12x

PBM's financial health

Profit margin

Revenue
$0.0
Net Income
-$647.8k
Profit Margin
0%
PBM's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials

Assets to liabilities

Assets
$12.7M
Liabilities
$28.7M
Debt to equity
-1.79
PBM's short-term liabilities ($16.18M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
PBM's long-term liabilities ($12.57M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
PBM's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
PBM's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$251.5k
Investing
$4.2M
Financing
-$3.9M
PBM's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

PBM vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
PBM$7.28M+0.18%-54.40x-0.45x
NEXI$7.15M-5.85%-0.16x0.87x
CYCN$7.13M-7.46%-0.57x0.55x
PULM$7.12M+8.33%-0.44x0.36x
KZIA$7.02M+3.01%-0.43x0.92x

Psyence Biomedical Stock FAQ

What is Psyence Biomedical's quote symbol?

(NASDAQ: PBM) Psyence Biomedical trades on the NASDAQ under the ticker symbol PBM. Psyence Biomedical stock quotes can also be displayed as NASDAQ: PBM.

If you're new to stock investing, here's how to buy Psyence Biomedical stock.

What is the 52 week high and low for Psyence Biomedical (NASDAQ: PBM)?

(NASDAQ: PBM) Psyence Biomedical's 52-week high was $14.55, and its 52-week low was $0.51. It is currently -96.26% from its 52-week high and 6.04% from its 52-week low.

How much is Psyence Biomedical stock worth today?

(NASDAQ: PBM) Psyence Biomedical currently has 13,390,659 outstanding shares. With Psyence Biomedical stock trading at $0.54 per share, the total value of Psyence Biomedical stock (market capitalization) is $7.28M.

Psyence Biomedical stock was originally listed at a price of $10.05 in Oct 20, 2021. If you had invested in Psyence Biomedical stock at $10.05, your return over the last 2 years would have been -94.59%, for an annualized return of -76.73% (not including any dividends or dividend reinvestments).

How much is Psyence Biomedical's stock price per share?

(NASDAQ: PBM) Psyence Biomedical stock price per share is $0.54 today (as of Feb 23, 2024).

What is Psyence Biomedical's Market Cap?

(NASDAQ: PBM) Psyence Biomedical's market cap is $7.28M, as of Feb 25, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Psyence Biomedical's market cap is calculated by multiplying PBM's current stock price of $0.54 by PBM's total outstanding shares of 13,390,659.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.